Section 217.5403 - Eligibility requirements for treatment with investigational drug, biological product, or deviceA patient shall be eligible for treatment with an investigational drug, biological product, or device if the patient has:
(1) A terminal illness that is attested to by the patient's treating health care provider;(2) Considered all other treatment options currently approved by the United States Food and Drug Administration;(3) Received a recommendation from the patient's treating health care provider for an investigational drug, biological product, or device;(4) Given written informed consent for the use of the investigational drug, biological product, or device; and(5) Documentation from the treating health care provider that the patient meets the requirements of this section.Added by 2017 Ky. Acts ch. 65,§ 3, eff. 6/29/2017.